Correlation Between Liaoning Chengda and Jiangsu Bioperfectus

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Liaoning Chengda and Jiangsu Bioperfectus at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Liaoning Chengda and Jiangsu Bioperfectus into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Liaoning Chengda Biotechnology and Jiangsu Bioperfectus Technologies, you can compare the effects of market volatilities on Liaoning Chengda and Jiangsu Bioperfectus and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Liaoning Chengda with a short position of Jiangsu Bioperfectus. Check out your portfolio center. Please also check ongoing floating volatility patterns of Liaoning Chengda and Jiangsu Bioperfectus.

Diversification Opportunities for Liaoning Chengda and Jiangsu Bioperfectus

0.63
  Correlation Coefficient

Poor diversification

The 3 months correlation between Liaoning and Jiangsu is 0.63. Overlapping area represents the amount of risk that can be diversified away by holding Liaoning Chengda Biotechnology and Jiangsu Bioperfectus Technolog in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Jiangsu Bioperfectus and Liaoning Chengda is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Liaoning Chengda Biotechnology are associated (or correlated) with Jiangsu Bioperfectus. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Jiangsu Bioperfectus has no effect on the direction of Liaoning Chengda i.e., Liaoning Chengda and Jiangsu Bioperfectus go up and down completely randomly.

Pair Corralation between Liaoning Chengda and Jiangsu Bioperfectus

Assuming the 90 days trading horizon Liaoning Chengda is expected to generate 2.4 times less return on investment than Jiangsu Bioperfectus. But when comparing it to its historical volatility, Liaoning Chengda Biotechnology is 1.56 times less risky than Jiangsu Bioperfectus. It trades about 0.03 of its potential returns per unit of risk. Jiangsu Bioperfectus Technologies is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  6,690  in Jiangsu Bioperfectus Technologies on December 27, 2024 and sell it today you would earn a total of  417.00  from holding Jiangsu Bioperfectus Technologies or generate 6.23% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Liaoning Chengda Biotechnology  vs.  Jiangsu Bioperfectus Technolog

 Performance 
       Timeline  
Liaoning Chengda Bio 

Risk-Adjusted Performance

Weak

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Liaoning Chengda Biotechnology are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, Liaoning Chengda is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Jiangsu Bioperfectus 

Risk-Adjusted Performance

Insignificant

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Jiangsu Bioperfectus Technologies are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Jiangsu Bioperfectus may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Liaoning Chengda and Jiangsu Bioperfectus Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Liaoning Chengda and Jiangsu Bioperfectus

The main advantage of trading using opposite Liaoning Chengda and Jiangsu Bioperfectus positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Liaoning Chengda position performs unexpectedly, Jiangsu Bioperfectus can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Jiangsu Bioperfectus will offset losses from the drop in Jiangsu Bioperfectus' long position.
The idea behind Liaoning Chengda Biotechnology and Jiangsu Bioperfectus Technologies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.

Other Complementary Tools

Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Equity Valuation
Check real value of public entities based on technical and fundamental data